ANIMO Ventures Backs Zócalo Health $15M Series A
ANIMO Ventures participated in Zócalo Health’s $15M Series A for community-based primary care, continuing to deploy its $78M Fund II.
investment-strategies
-
-
Temporal's $300M Series D: Durable Execution Is the Unsexy AI Infrastructure Winner
February 2026 Series D was $300 million at $5 billion post-money, a16z-led. That mark is historical. On September 14, 2026 Temporal announced a $550 million Series E at $12.55 billion.
-
Seattle's $1.5B Q1 2026: Fewer Deals, Bigger Checks, AI Dominates
Seattle's Q1 2026 saw 69 deals for $1.5B — the lowest deal count since mid-2020, reflecting a national AI-led capital concentration trend.
-
Lockheed Martin Ventures Goes to $1B: Strategic Capital Becomes a Defense-Tech Must-Have
LM Ventures' expansion from $400M to $1B is a signal that corporate strategic capital is now a core part of any defense-tech cap table.
-
Imaginary Ventures Leads Sweet Chemistry and Alec’s Ice Cream
Imaginary Ventures led a $1.5M seed in bioactive skincare startup Sweet Chemistry and an $11M Series A for regenerative-dairy brand Alec’s Ice Cream.
-
EUVC Summit 2026: The Curated GP + LP Gathering That Actually Moves Commitments
EUVC Summit & Awards on April 22 in London is one of the few EU events where LP allocations and GP relationships genuinely progress.